title: FPIN's clinical inquiries. Testosterone therapy and risk recurrence after treatment of prostate cancer.
authors.affiliation: Wayne State University School of Medicine, Detroit, MI, USA.
authors.forename: James
authors.initials: J
authors.lastname: Meza
authors.affiliation: Oakwood Health Care System, Wayne, MI, USA.
authors.forename: Karen
authors.initials: K
authors.lastname: Weaver
authors.affiliation: Wayne State University School of Medicine, Detroit, MI, USA.
authors.forename: Sandra
authors.initials: S
authors.lastname: Martin
mesh_terms: D000728:Androgens / Q000009:adverse effects / Q000627:therapeutic use*; D020249:Hormone Replacement Therapy / Q000009:adverse effects; D006801:Humans; D007006:Hypogonadism / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000139:chemically induced* / Q000517:prevention & control; D011183:Postoperative Complications / Q000188:drug therapy*; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000601:surgery*; D012306:Risk; D013739:Testosterone / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D000728:Androgens; D013739:Testosterone